Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Predictive Performance of SPECT/CT Bone Scan Quantification Before Lumbar Arthrodesis
NCT05183542Recruiting
- Sponsor
- CHRU de Nancy - Hôpital Central
- Start
- Apr 2022
- Primary completion
- Jan 2027
- Countries
- 1
01
Overview
Open-label, single-arm trial of technetium tc 99m oxidronate in pseudoarthrosis and chronic low back pain (CLBP), sponsored by CHRU de Nancy - Hôpital Central. Primary endpoint: Correlation of Standardized Uptake Value and response to surgery with Oswestry Disability Index at 24 months. Started Apr 2022; status: recruiting.
02
Drugs
technetium tc 99m oxidronate
03
Conditions
pseudoarthrosischronic low back pain (CLBP)
Beyond the preview
Go deeper on NCT05183542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05183542.